Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Civitas Therapeutics patents

Patents where

Current Assignee

Name

Civitas Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7947742 Inhalable epinephrine	Patent 7947742 was granted and assigned to Civitas Therapeutics on May, 2011 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	7947742	May 24, 2011
‌ US Patent 8415397 Inhalable epinephrine	Patent 8415397 was granted and assigned to Civitas Therapeutics on April, 2013 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8415397	April 9, 2013
‌ US Patent 9642812 Dosator apparatus for filling a capsule with dry powder	Patent 9642812 was granted and assigned to Civitas Therapeutics on May, 2017 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9642812	May 9, 2017
‌ US Patent 9717866 Powder inhaler devices	Patent 9717866 was granted and assigned to Civitas Therapeutics on August, 2017 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9717866	August 1, 2017
‌ US Patent 7954491 Low dose pharmaceutical powders for inhalations	Patent 7954491 was granted and assigned to Civitas Therapeutics on June, 2011 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	7954491	June 7, 2011
‌ US Patent 8945612 Capsules containing high doses of levodopa for pulmonary use	Patent 8945612 was granted and assigned to Civitas Therapeutics on February, 2015 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	8945612	February 3, 2015
‌ US Patent 9393210 Capsules containing high doses of levodopa for pulmonary use	Patent 9393210 was granted and assigned to Civitas Therapeutics on July, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9393210	July 19, 2016
‌ US Patent 9468728 Powder inhaler devices	Patent 9468728 was granted and assigned to Civitas Therapeutics on October, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9468728	October 18, 2016
‌ US Patent 8887715 Low dose pharmaceutical powders for inhalation	Patent 8887715 was granted and assigned to Civitas Therapeutics on November, 2014 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	8887715	November 18, 2014
‌ US Patent 8454939 Low dose pharmaceutical powders for inhalation	Patent 8454939 was granted and assigned to Civitas Therapeutics on June, 2013 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8454939	June 4, 2013
‌ US Patent 8404276 Pulmonary delivery for levodopa	Patent 8404276 was granted and assigned to Civitas Therapeutics on March, 2013 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8404276	March 26, 2013
‌ US Patent 9333174 Use of simple amino acids to form porous particles	Patent 9333174 was granted and assigned to Civitas Therapeutics on May, 2016 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	9333174	May 10, 2016
‌ US Patent 9295661 Methods for reducing inter-patient variability of levodopa plasma concentrations	Patent 9295661 was granted and assigned to Civitas Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9295661	March 29, 2016
‌ US Patent 8747813 Inhalable epinephrine	Patent 8747813 was granted and assigned to Civitas Therapeutics on June, 2014 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	8747813	June 10, 2014
‌ US Patent 9539211 Ultra low density pulmonary powders	Patent 9539211 was granted and assigned to Civitas Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9539211	January 10, 2017
‌ US Patent 8496002 Powder inhaler devices	Patent 8496002 was granted and assigned to Civitas Therapeutics on July, 2013 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8496002	July 30, 2013
‌ US Patent 8628754 Highly efficient delivery of a large therapeutic mass aerosol	Patent 8628754 was granted and assigned to Civitas Therapeutics on January, 2014 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8628754	January 14, 2014
‌ US Patent 9387169 Rapamycin powders for pulmonary delivery	Patent 9387169 was granted and assigned to Civitas Therapeutics on July, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9387169	July 12, 2016
‌ US Patent D755367 Indicator for an inhaler	Patent D755367 was granted and assigned to Civitas Therapeutics on May, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	D755367	May 3, 2016
‌ US Patent D752204 Indicator for an inhaler	Patent D752204 was granted and assigned to Civitas Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	D752204	March 22, 2016
‌ US Patent 8685442 Capsules containing high doses of levodopa for pulmonary use	Patent 8685442 was granted and assigned to Civitas Therapeutics on April, 2014 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	8685442	April 1, 2014
‌ US Patent D752734 Inhaler grip	Patent D752734 was granted and assigned to Civitas Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	D752734	March 29, 2016
‌ US Patent 9155699 Pulmonary delivery for levodopa	Patent 9155699 was granted and assigned to Civitas Therapeutics on October, 2015 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	9155699	October 13, 2015
‌ US Patent 10034857 Triptan powders for pulmonary delivery	Patent 10034857 was granted and assigned to Civitas Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Civitas Therapeutics	Civitas Therapeutics	United States Patent and Trademark Office	10034857	July 31, 2018
‌ US Patent 8268358 Use of simple amino acids to form porous particles	Patent 8268358 was granted and assigned to Civitas Therapeutics on September, 2012 by the United States Patent and Trademark Office.		Civitas Therapeutics	United States Patent and Trademark Office	8268358	September 18, 2012

Results per page:

30 results

0 selected

30 results

0 selected